ALK-Abelló A/S (OTCMKTS:AKBLF – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 133,283 shares, an increase of 64.3% from the August 15th total of 81,130 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.
ALK-Abelló A/S Stock Performance
Shares of OTCMKTS:AKBLF opened at $32.47 on Friday. The firm has a fifty day moving average price of $36.99 and a 200 day moving average price of $36.19. ALK-Abelló A/S has a fifty-two week low of $28.95 and a fifty-two week high of $40.65.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Recommended Stories
- Five stocks we like better than ALK-Abelló A/S
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
